Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
AML, Acute Myeloid Leukemia: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
Akt↓, JNK↑, Mcl-1↓, cl‑Bcl-2↓, Casp3↑, Casp7↑, Casp9↑, cl‑PARP↑, mTOR↓, GSK‐3β↓,
Apoptosis↑, Akt↓, P53↑, FOXO1↑, GSK‐3β↑, TumVol↓, QoL↑, BBB↑, OS↑, Dose↝, MMP↓, ROS↑, XIAP↑, Casp9↑, Casp8↑, Casp3↑, cl‑PARP↑, TumCCA↑,
| - |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vivo, |
AML, |
NA |
|
|
|
TumCP↓, Apoptosis↑, TumCG↓, PDK1↓, cl‑PARP↑, Bcl-xL↓, Bcl-2↓, Beclin-1↓, ATG3↓, PI3K↓, Akt↓, eff↑,
ROS↑, mt-Apoptosis↑, TumCCA↑, PI3K↓, Akt↓, STAT3↓, Dose↝, *hepatoP↑, Casp8↑, mtDam↑, TumCD↑, selectivity↑, DNAdam↑, BAX↑, P53↑, Bcl-2↓, CSCs↓, *toxicity↓, tumCV↓, Imm↑, FAK↓, mTOR↓, ChemoSen↑, eff↝, eff↑,
Dose↝, TumCG↓, Apoptosis↑, TumCCA↑, DNAdam↑, Akt↓, Bcl-2↓, PCNA↓,
| - |
in-vitro, |
AML, |
RAW264.7 |
|
|
|
p‑IκB↓, NF-kB↓, p‑ERK↓, p‑JNK↓, p‑PI3K↓, p‑Akt↓, iNOS↓, COX2↓,
Casp3↑, Casp9↑, Casp8↑, cl‑PARP↑, Apoptosis↑, Mcl-1↓, Akt↓, JNK↑, eff↑,
AntiAg↑, TumCG↓, Apoptosis↑, PI3K↓, Akt↓, mTOR↓, p38↑, Casp3↑,
CK2↓, PI3K↓, TumCD↑, Akt↓, Mcl-1↓, PTEN↑,
Apoptosis↑, selectivity↑, TumAuto↓, PI3K↓, Akt↓,
Showing Research Papers: 1 to 10 of 10
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 10
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1, mtDam↑, 1, XIAP↑, 1,
Core Metabolism/Glycolysis ⓘ
PDK1↓, 1,
Cell Death ⓘ
Akt↓, 9, p‑Akt↓, 1, Apoptosis↑, 6, mt-Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 3, cl‑Bcl-2↓, 1, Bcl-xL↓, 1, Casp3↑, 4, Casp7↑, 1, Casp8↑, 3, Casp9↑, 3, CK2↓, 1, iNOS↓, 1, JNK↑, 2, p‑JNK↓, 1, Mcl-1↓, 3, p38↑, 1, TumCD↑, 2,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Autophagy & Lysosomes ⓘ
ATG3↓, 1, Beclin-1↓, 1, TumAuto↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 2, P53↑, 2, cl‑PARP↑, 4, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
CSCs↓, 1, p‑ERK↓, 1, FOXO1↑, 1, GSK‐3β↓, 1, GSK‐3β↑, 1, mTOR↓, 3, PI3K↓, 5, p‑PI3K↓, 1, PTEN↑, 1, STAT3↓, 1, TumCG↓, 3,
Migration ⓘ
AntiAg↑, 1, FAK↓, 1, TumCP↓, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, Imm↑, 1, p‑IκB↓, 1, NF-kB↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, Dose↝, 3, eff↑, 3, eff↝, 1, selectivity↑, 2,
Functional Outcomes ⓘ
OS↑, 1, QoL↑, 1, TumVol↓, 1,
Total Targets: 60
Pathway results for Effect on Normal Cells:
Functional Outcomes ⓘ
hepatoP↑, 1, toxicity↓, 1,
Total Targets: 2
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:2 Cells:% prod#:% Target#:4 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page